Chemotherapy-induced peripheral neuropathy (CIPN) is a common clinical dose-limiting adverse
drug reaction, and the primary manifestations are different degree of neuromotor,
sensorineural and autonomic nervous dysfunction.
Phase:
Phase 3
Details
Lead Sponsor:
Lee's Pharmaceutical Limited
Collaborators:
Shanghai Changzheng Hospital Shanghai Jiao Tong University School of Medicine